WallStSmart

Colgate-Palmolive Company (CL)vsThe Clorox Company (CLX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 202% more annual revenue ($20.38B vs $6.76B). CLX leads profitability with a 11.2% profit margin vs 10.5%. CLX appears more attractively valued with a PEG of 2.17. CL earns a higher WallStSmart Score of 56/100 (C).

CL

Buy

56

out of 100

Grade: C

Growth: 4.7Profit: 8.5Value: 4.7Quality: 3.3
Piotroski: 3/9

CLX

Buy

51

out of 100

Grade: C-

Growth: 2.0Profit: 7.5Value: 7.3Quality: 5.3
Piotroski: 5/9Altman Z: 2.08
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLSignificantly Overvalued (-279.8%)

Margin of Safety

-279.8%

Fair Value

$22.51

Current Price

$85.49

$62.98 premium

UndervaluedFair: $22.51Overvalued
CLXSignificantly Overvalued (-203.1%)

Margin of Safety

-203.1%

Fair Value

$41.55

Current Price

$104.76

$63.21 premium

UndervaluedFair: $41.55Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL4 strengths · Avg: 8.8/10
Return on EquityProfitability
49.7%10/10

Every $100 of equity generates 50 in profit

Market CapQuality
$67.75B9/10

Large-cap with strong market position

Operating MarginProfitability
20.4%8/10

Strong operational efficiency at 20.4%

Free Cash FlowQuality
$1.28B8/10

Generating 1.3B in free cash flow

CLX2 strengths · Avg: 9.0/10
Return on EquityProfitability
98.7%10/10

Every $100 of equity generates 99 in profit

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

Areas to Watch

CL4 concerns · Avg: 3.3/10
P/E RatioValuation
32.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
1.1%4/10

1.1% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.262/10

Expensive relative to growth rate

CLX3 concerns · Avg: 2.7/10
PEG RatioValuation
2.174/10

Expensive relative to growth rate

Revenue GrowthGrowth
-0.8%2/10

Revenue declined 0.8%

EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Market Cap, Operating Margin.

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, P/E Ratio.

Bear Case : CL

The primary concerns for CL are P/E Ratio, EPS Growth, Piotroski F-Score. Debt-to-equity of 147.93 is elevated, increasing financial risk.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

CL profiles as a value stock while CLX is a declining play — different risk/reward profiles.

CLX carries more volatility with a beta of 0.57 — expect wider price swings.

CL is growing revenue faster at 5.8% — sustainability is the question.

CL generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

CL scores higher overall (56/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Want to dig deeper into these stocks?